Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days.
Hashimoto
Masayoshi
M
Akita
Hozuka
H
D000368:Aged; D001161:Arteriosclerosis / Q000503:physiopathology; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000503:physiopathology; D004730:Endothelium, Vascular / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000503:physiopathology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000188:drug therapy; D007700:Kinetics; D005996:Nitroglycerin / Q000494:pharmacology; D011725:Pyridines / Q000627:therapeutic use*; D015203:Reproducibility of Results; D014463:Ultrasonography / Q000379:methods; D014664:Vasodilation / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011725:Pyridines; D014665:Vasodilator Agents; C086276:cerivastatin; D005996:Nitroglycerin